Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 16, 2026.

The Role of Reactive Oxygen Species (ROS) in the Biological Activities of Metallic Nanoparticles

Ahmed Abdal Dayem, Mohammed Hossain, Soo Lee and 5 more

International Journal of Molecular Sciences · 2017 · Review · CC BY

doi:10.3390/ijms18010120

Abstract

Nanoparticles (NPs) possess unique physical and chemical properties that make them appropriate for various applications. The structural alteration of metallic NPs leads to different biological functions, specifically resulting in different potentials for the generation of reactive oxygen species (ROS). The amount of ROS produced by metallic NPs correlates with particle size, shape, surface area, and chemistry. ROS possess multiple functions in cellular biology, with ROS generation a key factor in metallic NP-induced toxicity, as well as modulation of cellular signaling involved in cell death, proliferation, and differentiation. In this review, we briefly explained NP classes and their biomedical applications and describe the sources and roles of ROS in NP-related biological functions in vitro and in vivo. Furthermore, we also described the roles of metal NP-induced ROS generation in stem cell biology. Although the roles of ROS in metallic NP-related biological functions requires further investigation, modulation and characterization of metallic NP-induced ROS production are promising in the application of metallic NPs in the areas of regenerative medicine and medical devices.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 16, 2026. Paragraph numbers are ours, so an answer can point at one.

1. Introduction

Reactive oxygen species (ROS) are natural byproducts of cellular oxidative metabolism and play important roles in the modulation of cell survival, cell death, differentiation, cell signaling, and inflammation-related factor production. Biologically-significant ROS elements include free radicals, such as singlet oxygen (1O2), superoxide (O2•–), hydroxyl (HO•), hydroperoxyl (HO2•), carbonate (CO3•–), peroxyl (RO2•), alkoxyl (RO•), and carbon dioxide radical (CO2•–), and nonradicals, such as hydrogen peroxide (H2O2), hypobromous acid (HOBr), hypochlorous acid (HOCl), ozone (O3), organic peroxides (ROOH), peroxynitrite (ONOO–), peroxynitrate (O2NOO–), peroxynitrous acid (ONOOH), peroxomonocarbonate (HOOCO2–), nitric oxide (NO), and hypochlorite (OCl–).

O2•– is a free radical with a short biological lifespan attributed to its rapid reduction to H2O2, which is mediated by superoxide dismutases (SODs). However, H2O2 is a non-radical derivative of ROS, with a long biological lifespan and higher stability as compared with free radicals. Mitochondria and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) generate superoxide, which can inactivate specific enzymes or initiate lipid peroxidation (Figure 1A). Incomplete electron reduction of O2 leads to superoxide production and ultimately conversion into H2O2 by SOD, which constitutes a key antioxidant defense present in nearly all cells exposed to oxygen. There are three forms of SOD, including SOD1 (a copper- and zinc-ion-containing SOD primarily located in the cytoplasm), SOD2 (a manganese-ion-containing mitochondrial SOD), and SOD3 (a copper- and zinc-ion-containing extracellular SOD).

Under various physiological states, ROS are produced as intermediates, and their cellular levels are strongly regulated by various detoxifying enzymes, such as SOD, glutathione peroxidase (GPX), and catalase (CAT), or by different antioxidants, including flavonoids, ascorbic acids, vitamin E, and glutathione (GSH). There are significant correlations between ROS generation and metabolism, as well as with cellular pathophysiology.

Reduction-oxidation (redox) imbalance represents a defect in the balance between ROS generation and the neutralization of excess ROS by cellular antioxidant factors. Disturbed redox homeostasis leads to harmful effects on cells mediated by interference with cell-signaling mechanisms or resulting in oxidative damage to biomolecules, such as proteins, lipids, and nucleic acids. By contrast, modulation of ROS generation enhances activation of key signaling molecules that regulate cell death, survival, differentiation, and proliferation.

Nanotechnology is a branch of science that deals with tiny materials and their surfaces with dimensions <100 nm. This field has rapidly developed in the 21st century, with gradual advances in novel applications. Engineered nanoparticles (NPs) exhibit specific physicochemical characteristics and are manufactured for applications in several biological and commercial functions. The unique biological and chemical, thermal, and electrical characteristics of NPs make them valuable in numerous applications in the areas of commercial industry, agriculture, medicine, cosmetics, clothing, and food. The absolute diversity of the physicochemical characteristics of NPs also creates research opportunities pertaining to their toxic effects.

NPs internalization into the human body can be facilitated via various routes, including inhalation, oral intake, and skin absorption. Following uptake, they are introduced to the biological environment, where they interact with cellular molecules present in body fluids. The protein corona occurs as a result of NP surfaces being coated with cellular molecules, which enables recognition of NP biological identity. Investigations into the cellular toxicity and phototoxicity of NPs are required for the safe development and use of nanotechnology and commercial NPs, because NP-mediated toxicity can potentially result in inflammation, oxidative stress, genetic damage, inhibition of cell division, and cell death.

NP-mediated ROS generation initiates a sequence of pathological events, including inflammation, fibrosis, genotoxicity, and carcinogenesis, and is modulated by physicochemical features of NPs, such as size, charge, surface area, and chemical structure. NP-related toxicity can trigger increased expression of pro-inflammatory and fibrotic cytokines and activation of inflammatory cells, such as macrophages and neutrophils, which can influence the enhanced generation of ROS.

The mechanism associated with NP-induced ROS generation varies among different NPs, and the core cellular mechanism related to ROS production remains unexplained. The majority of metal-based NPs may provoke free-radical-facilitated toxicity via Fenton-type reactions. Since ROS generation is a key byproduct of NP-induced injury or modulation of cellular function, in this review, we discussed the sources of ROS generation, NPs classes and their biomedical applications, the sources and roles of ROS in NP-related biological functions, and the mechanisms of ROS-mediated biological activities associated with NPs in various cells.

2. Sources of Reactive Oxygen Species (ROS) Generation

The main sources of intracellular ROS are mitochondria, the endoplasmic reticulum (ER), peroxisomes, microsomes, and NOX complexes (seven distinct isoforms) in cell membranes (Figure 1A). Specifically, mitochondria represent the main intrinsic source of ROS generation via the mitochondrial electron-transport system (Figure 1B). Increased accumulation of calcium (Ca2+) in the cytoplasm results in activation of the mitochondrial electron-transport chain and ROS generation. During mitochondrial production of adenosine triphosphate (ATP) and water, small concentrations of oxygen are produced, resulting in the early stages of ROS production. The superoxide anion, the first ROS element generated by mitochondria, is produced by complex I (NADH ubiquinone oxidoreductase) and complex III (co-enzyme Q, bc1 complex, and uniquinone/cytochrome c reductase) activity in the mitochondrial matrix and intermembrane space, respectively. In the intermembrane space, metals, such as Cu, Mn, and Zn-SOD, catalyze the conversion of superoxide anions into H2O2 (stable form). Monoamine oxidase and α-ketoglutarate dehydrogenase are also potential sources of mitochondrial ROS generation.

NOX represents a non-mitochondrial source of ROS generation and plays pivotal role in superoxide formation via oxygen reduction mediated by the electron donor NADPH. Mammalian NOX is composed of seven isoforms (NOX1-5, Dual oxidase 1 (DUOX1), and DUOX2), the majority of which generate superoxide, whereas NOX4, DUOX1, and DUOX2 generate H2O2.

The ER is a cellular organelle that also plays a key role in ROS production. The ER lumen represents a suitable oxidizing environment (with a high ratio of oxidized-to-reduced forms of GSH) for protein folding and formation of disulfide bonds.

Additionally, there are various cellular enzymes, including xanthine oxidoreductase, nitric oxide (NO) synthase, cytochrome P450 monoxygenase, lipoxygenase, and cyclooxygenase, implicated in the process of ROS generation. ONOO–, which is considered a potent oxidizing and nitrating agent, results from interaction between NO and O2•–.

Extracellular sources of ROS generation include ROS-inducing agents, such as radiation, pollutants, and exposure to nanomaterials (Figure 1A). Oxidative stress initiates defense strategies associated with macrophages and neutrophils against microbial invasion, cancer, and the exposure to pollutants. Given the role of iron in the Fenton reaction, which is implicated in the formation of hydroxyl radicals, free iron (Fe2+) is a critical factor related to toxicity induced by ROS generation.

3. Nanoparticle (NP) Classes and Biomedical Applications

Based on their preparation, NPs can be broadly classified into two main classes: organic NPs, include dendrimers, liposomes, carbon-based nanomaterials, and polymeric micelles, and inorganic NPs, including metal and metal oxides, quantum dots (QDs), and magnetic NPs.

Metallic NPs can be synthesized and modified with various surface functionalities, which allow them to be conjugated with antibodies, ligands, and drugs, thereby increasing their potential applications in biotechnology, magnetic separation, drug and gene delivery, and imaging. Recently, metallic NPs, such as magnetic NPs (iron-oxide NPs (IONPs)), silver NPs (AgNPs), gold NPs (AuNPs), and QDs, have been consistently used and adapted to enhance their functions as diagnostic and therapeutic agents. These applications are briefly described in subsequent sections (Figure 2A).

3.1. Optical Imaging

Fluorescence proteins and luciferase bioluminescence-based techniques commonly used for imaging possess many drawbacks associated with low intensity, low stability, and poor optimization. Fortunately, NP applications offer possibilities to overcome these limitations. In this context, various markers can be detected simultaneously using QDs and based on their high quantum properties. Various reports attributed the broad application of various metallic NPs, such as AgNPs, AuNPs, and aluminum (Al) NPs in the imaging to their plasmonic properties. The application of superparamagnetic IONPs (SPIONS) overcomes the low sensitivity of magnetic resonance imaging by boosting the contrast of magnetic imaging.

3.2. Biosensing

Biosensor is device for detection of biological elements, such as nucleic acids, cells, protein, microorganisms, and enzymes, which ultimately analyze the biological alterations. It mainly composed of biological recognition components (bio-transducer and bio-receptor). Enormous scientific efforts are designated to discover highly sensitive and economical biosensors. NPs can also be applied as sensors for chemicals and biological molecules. For example, the presence of heavy metals, fungal toxins, and microbes in water, as well as the nutritional value of soil and agricultural pests, can be detected and estimated using NPs or nanosensors. AuNPs are widely applied in biosensing, which is ascribed to their biocompatibility, unique optical and electric characteristics, and the convenience of their production and surface modifications. AuNPs, in particular, possess surface plasmon resonance properties that allow the electrons to oscillate upon irradiation with single-wavelength light. This oscillation is dependent on the particle size, shape, and the dielectric constant. The alteration on the oscillation and the resulted color led to visual recognition of the changes in the surrounding environment. Accordingly, there are a wide range of nanomaterials as colorimetric biosensors has been emerged for the bio-analysis of DNA or immunity related molecules. Immunoassays with high sensitivity and specificity were developed using AuNPs for detection of anti-protein A, and coating of AuNPs with immunoglobulin G allows for a highly sensitive immunoassay to detect even small amounts of antigens in samples using the hyper-Rayleigh scattering method. However, these two methods are only able to identify proteins at the microgram level, which confines their uses in immunoassays specifically for early cancer diagnosis.

3.3. Diagnostic Applications

NPs can combine with other specific materials to allow for highly accurate diagnoses at the molecular level. There are various commercial nanomaterials available for medical diagnostic purposes that have been previously reviewed elsewhere.

The potentials of NPs for use as tags of DNA, proteins, microbes, and other cellular molecules make them promising materials for various diagnostic applications.

3.4. Drug Delivery

NPs enable the delivery of various drugs in several biomedical areas. NP-mediated drug delivery is more advantageous than use of conventional methods in terms of their high specificity, low side effects, and cost-effectiveness.

Previous studies reported the ability of NPs to deliver multiple drugs, which is efficient for the treatment of complicated diseases. In this context, loading of DNA oligonucleotides to Au nanorods via thiol conjugation resulted in the efficient release of DNA while maintaining its functionality following release. The release of DNA from the Au nanorods was modulated by ultrafast laser radiation, which selectively melted the nanorods through longitudinal surface-plasmon resonance. The application of AuNPs exhibited highly efficient delivery of the anticancer drug oxaliplatin, which was successfully transported to the nucleus of lung cancer cells without any signs of cytotoxicity. This method obviated the hurdles of dose-associated side effects and previously observed resistance to anticancer drugs.

3.5. Other Applications

The unique physicochemical properties of NPs together with their biocompatibility make them ideal for various applications, including in cosmetics, for tissue regeneration, and as antimicrobial, anticancer, anti-inflammatory, and detoxifying agents. The potent antimicrobial, anticancer, and wound-healing potential of AgNPs was previously reported, with Zn and titanium (Ti) NPs also exhibiting successful applications in dermatology.

4. Mechanisms Associated with NP-Induced ROS Generation

NP-related ROS generation is governed by the following factors: NPs internalization, particle chemistry, and physical properties (size and surface area). The mechanism of NP-induced ROS generation involving NP-related factors implicated in ROS generation and the interaction of NPs with cellular components is described in this section (Figure 2B).

4.1. NP-Related Factors Implicated in ROS Generation

The potential of various nanomaterials with different chemical structures to generate ROS associated with their hazardous and toxic effects has been well-characterized in previous studies. Compared with microparticles or their bulk of origin, NPs possess unique physicochemical properties (size, surface area, shape, solubility, and aggregation status) that correlate with their potential to generate ROS.

NPs differ significantly from their bulk counterparts in terms of surface area, the latter of which is significantly larger and also contains a higher fraction of atoms. Particle mass, which represents the surface-to-volume ratio, is inversely correlated with particle size. Smaller NPs are associated with larger surface areas and mass; therefore, particle size regulates the number of reactive sites on the NP surface. Moreover, chemical reactions are significantly accelerated with NPs with larger surface area. The high chemical reactivity of NPs is attributed to the dangling bonds (immobilized free radicals) of the atoms located on the NP surface that promote NP-induced biochemical catalysis. Compared with larger NPs, smaller NPs result in structural modifications and alterations in the electronic properties of the particle surface, ultimately resulting in formation of reactive groups on particle surfaces. Previous studies showed that silicon NPs and ZnO NPs with the same size and shape exhibited different degrees of toxicity attributed to differences in their surface properties. For example, ZnO NPs possess higher chemical activity as compared with that shown by silicon oxide (SiO2) NPs and, as a consequence, produce higher levels of oxidative stress caused by the production of O2•–.

Previous reports illustrated the impact of reactive surfaces of NPs in ROS production. The oxidants and free radicals located on the particle surface modulate ROS generation. For example, the production of ROS (HO• and O2•–) from quartz particles is ascribed to the presence of surface-bound radicals, such as SiO• and SiO2•. Additionally, adsorption of ambient particulate matter, such as ozone and nitrogen oxide, onto the NP surface boosts its potential to generate high levels of oxidative stress.

Aqueous suspensions of quartz particles produce H2O2, HO•, and 1O2. Despite surface-dependent properties, chemical compounds and metals present on the NP surface increase the speed of ROS reactions.

There are various transition metals, including Si, Fe, copper (Cu), chromium (Cr), and vanadium, that are implicated in ROS generation through Haber-Weiss and Fenton reaction mechanisms. In Fenton reactions, a transition metal ion reacts with H2O2 to yield HO• and an oxidized metal ion. Additionally, the reduction of H2O2 with ferrous iron (Fe2+) also culminates in creation of HO• that is exceedingly sensitive and toxic to biological molecules.

Metallic NPs, such as Cu and Fe, influence oxidative stress (O2•– and HO•) via Fenton reactions, whereas Haber-Weiss reactions represent the reactions between oxidized metal ions and H2O2 to produce HO•. NPs containing Cr, cobalt (Co), and vanadium (Va) can catalyze both Fenton and Haber-Weiss reactions, and Fenton reactions are involved in IONP-induced ROS generation.

Quantum confinement effects are also play a critical roles in the unique function of QDs NPs. Nanomaterials exhibiting quantum-confinement effects possess magnetic moments that are absent in original bulks. Quantum confinement also modulates NP affinity to accept or donate electrical charges that, in turn, influence their catalytic behavior. Compared with their original bulk material, atoms located on the NP surface have fewer neighboring atoms that can potentially decrease the binding energy of each atom. As a consequence, NP melting temperature is lower than that of the bulk material according to the Gibbs-Thomson equation.

Some NPs activated upon exposure to photon energy (ultraviolet/visible irradiation), such as TiO2 NPs and QDs, produce electrons that possess energy capable of converting O2 into 1O2, which is implicated in cellular damage mediated by interactions with cellular proteins, lipids, and nucleic acids.

4.2. NP- and Cellular-Component-Induced ROS Generation

In order to invade the cell, NPs need to interact with cell membranes possessing unique properties that modulate the exchange of various ions and molecules from the external environment (Figure 2B). Protein aggregation, lipids, lipoproteins, and nanomaterials can be transported to and from cells via encapsulation within vesicles by endocytosis (transportation into cells) and exocytosis (transportation outside of cells). Endocytosis can be dependent or independent of caveolin or clathrin proteins and plays an important role in cellular internalization of NPs.

Factors involved in the NP-induced intracellular ROS generation include catalysis of free-radical reactions, interaction with mitochondrial components, activation of growth factors, and activation of NOX.

Mitochondria represent a key organelle involved in NP-related generation of cellular ROS. The ability of NPs to depolarize the mitochondrial membrane and to interfere with the electron-transport chain through activation of NADPH-related enzymes was previously described. The mitochondrial electron-transport chain can be blocked following exposure to NPs, thereby increasing cellular levels of O2•– via electron transfer from respiratory carriers to O2. AgNP-exposed human glioblastoma and human fibroblast cells showed increased accumulation of AgNPs in mitochondria that led to disruption of the mitochondrial electron-transfer chain and, consequently, high levels of ROS-mediated cytotoxicity. The interaction of Ag ions with NADH dehydrogenase, which blocks electron transfer to O2 and generation of high levels of ROS, was shown in Escherichia coli. Additionally, NP exposure leads to activation of immune cells in an ROS-dependent mechanism, which is mediated by NOX activation.

NP-induced production of free radicals leads to reduction of GSH into its oxidized form, glutathione disulfide, which is implicated in oxidative stress and its consequences.

Activation of ROS-associated enzymes and receptors by NPs is also involved in NP-induced generation of intracellular ROS. For example, metal oxide NPs (Ni2O3, Mn2O3, Co3O4, CoO, and Cr2O3 NPs) result in high level of oxidative-stress-mediated toxicity attributed to NADPH oxidation into NADP+, as well as cytochrome c oxidation. This effect is correlated with band-gap energy levels associated with these NPs.

5. Biological Functions Modulated by NP-Induced ROS Production

The amount of ROS generated, and the resulting oxidative stress, are correlated with the nanomaterial concentration to which cells are exposed. Cells exposed to low NP concentrations showed potent antioxidant defenses capable of overcoming oxidative stress and recovering the redox balance. By contrast, exposure to high NP concentrations overwhelms antioxidant systems and results in cytotoxicity and inflammation.

ROS elements, such as O2•–, HO•, and H2O2, are significant intermediates that are generated from physiological processes, including photosynthesis, respiration, and cell signaling, and their concentration inside cells is acutely regulated by enzymes, such as SOD, CAT, and GPX, or antioxidants, including ascorbic acid, cysteine, glutathione, and bilirubin. Redox homeostasis can be disrupted as a result of numerous disorders, with oxidative stress representing ROS surges that can result in harm to cells via oxidative damage.

Oxidative stress is a key factor involved in nanotoxicity, as well as in alterations to cell motility, cytotoxicity, unregulated cell signaling, DNA damage, apoptosis, and cancer proliferations and metastasis. The role of ROS in NP-induced biological functions in cells and the molecular mechanisms involved is outlined in the following subsections (Figure 2B).

5.1. DNA Damage and Cytotoxicity

The link between metallic NPs and chromosomal aberrations and oxidative damage to DNA was previously reported. The potential of NPs to cause DNA damage can be attributed to the generation of the free radical HO•, which interacts with DNA to form 8-hydroxyl-2′-deoxyguanosine (8-OHdG) that ultimately leads to DNA damage. In HO•− mediated DNA damage, 8-OHdG is significantly increased during in vitro and in vivo exposure to NPs. Interestingly, an in vivo study showed that exposure to Ag, Ti, Fe, or Cu NPs leads to nucleic acid damage-mediated genotoxicity.

At the beginning of ROS generation, oxidation of polyunsaturated fatty acids occurs, followed by production of lipid peroxides. Lipid peroxidation-associated mutations are also implicated in metal NP-induced genotoxicity.

A combination of nanomaterials induce toxicity mediated by ROS in numerous biological systems, including skin fibroblasts, human erythrocytes, and different tumor cells. The implication of oxidative-stress-mediated upregulation of key signaling pathways involved in activation of inflammatory factors, such as tumor necrosis factor-α and interleukins, was previously reported. ROS is also involved in inflammatory responses that enhanced by metallic NPs (TiO2 NPs and SiO2 NPs).

In human lung fibroblasts, AuNP exposure results in high levels of oxidative stress that occur simultaneous to the up-regulation of autophagy evident from increases in microtubule-associated protein 1 light-chain 3 (LC3) and autophagy gene 7. Adenosine monophosphate-treated human lung fibroblasts exhibited oxidative damage that provided evidence of malondialdehyde (MDA) protein adducts and increased expression of antioxidant genes. Autophagy is considered a protective mechanism against AuNP-induced cell toxicity.

ZnO NPs enhance cytotoxicity, which primarily occurs through ROS generation, which triggers oxidative injury and release of inflammatory mediators that ultimately lead to cell death in phagocytic RAW 264.7 cells and transformation in human bronchial epithelial BEAS-2B cells. An Au-Co nanoalloy-induced alteration in tumor-initiating genes associated with an increase of micronuclei formation and generation of 8-OHdG was identified in mice as a result of increases in oxidative stress.

In human epidermal keratinocytes, treatment of single-walled carbon nanotubes (SWCNTs) leads to cytotoxicity accompanied by oxidative stress indicated by detection of free radicals and increases in peroxidation. In addition, TiO2 NP-exposed human epidermal cells showed oxidative stress-mediated genotoxicity, as presented by the formation of micronucleus and DNA degradation (Figure 3). These findings indicated that oxidative stress is a crucial mediator in the dermal toxicity of nanomaterials.

In NIH3T3 fibroblast cells, AgNP-induced apoptosis is correlated with ROS generation and activation of c-Jun N-terminal kinase (JNK) signaling. AgNP-exposed NIH3T3 cells exhibited release of cytochrome c into the cytoplasm and detection of Bax in the mitochondria, indicating a role for mitochondria in AgNP-induced ROS generation. Suppression of both ROS and JNK signaling abrogated AgNP-induced apoptosis in NIH3T3 cells. Additionally, in mouse lymphoma cells, AgNPs stimulated mutations and oxidative stress facilitated by ROS formation. Autophagy is a primary response to AgNP-induced oxidative stress in NIH3T3 cells, as indicated by up-regulation of LC3 and autophagosome formation.

5.2. Antimicrobial Function

NP-induced oxidative stress can be exploited for killing a wide range of pathogens. Specially, the emergence of the antibiotic resistance in various bacteria, which hinder the efficiency of the antimicrobial therapy, has incited the need for discovery of new antibacterial mechanisms. Several research reports evidenced the role of oxidative stress in NP-induced antimicrobial activity. Biologically-synthesized AgNPs showed potent antimicrobial activity against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus. The significant antimicrobial effect of AgNP is attributed to its potential up-regulation of ROS and reactive nitrogen intermediates that eventually leads to killing of the bacteria. ROS are involved in the significant antibacterial activity of ZnO NPs. The role of singlet oxygen and hydroxyl radicals in the antifungal activity of ZnO NPs against Candida albicans has been proved. Iron oxide NP(IONPs) that coated with the positively charged chitosan possesses special interface that showed significant production of ROS, which is involved in its significant antimicrobial activity against Escherichia coli and Bacillus subtilis (Figure 4).

5.3. Cellular Differentiation

NP-induced modulation of ROS generation plays important roles in cellular differentiation. Our research group showed the potential of biologically synthesized AgNPs to significantly generate ROS and to promote neurite growth in human neuroblastoma SH-SY5Y cells (Figure 5).

In K562 cells, nitrogen-doped TiO2 NPs together with light energy of 12 J/cm2 (NP-based photodynamic therapy (PDT)) enhanced megakaryocytic terminal differentiation, which is mediated by autophagy. Pharmacological inhibition of autophagy abrogated the effect of NP-based PDT to trigger the differentiation of K562 cells, and pretreatment with ROS-scavenging compounds suppressed the observed differentiation. These findings indicated that ROS is an upstream modulator of NP-based PDT-mediated terminal differentiation of megakaryocytes.

5.4. Anticancer

High levels of oxidative stress and aerobic glycolysis are hallmarks of tumor cells. Oxidative stress is associated with abnormal growth of tumor cells, which is attributed to redox imbalance or disturbance of ROS-scavenging. Additional oxidative stress from exposure to ROS-inducing agents leads to cell death due to toxicity induced by excess ROS production. In this regard, the ability of NPs to generate ROS could potentially be exploited for cancer therapy.

In MCF-7 human breast cancer cells, Zn-doped TiO2 NP exposure leads to drastic decreases in cell viability and increased cell cycle arrest associated with increases in oxidative stress. The oxidative stress induced in Zn-doped TiO2 NP-treated MCF-7 cells was indicated by depletion of GSH, decreases in SOD expression, and increases in the expression of the heme oxygenase-1 gene. This cytotoxicity was abrogated following treatment with N-acetyl-cysteine.

A previous study reported a role for p53 in cytotoxicity induced by ZnO NPs. The exposure to low concentrations of ZnO NPs leads to upregulation of p53 that subsequently enhances the expression of antioxidant genes, including ALDH4A1, GPX1, SOD2, SESN1, and SESN2, whereas high concentrations of ZnO NPs result in the robust generation of ROS that trigger p53-induced apoptotic cell death. Cancer cells lacking p53, such as DLD-1 and SW480 cells, were more susceptible to toxicity induced by ZnO NPs.

The anticancer effect of NP-induced ROS generation can be attributed to apoptosis, necrosis, and autophagy. In MDA-MB-231 human breast cancer cells, AgNP exposure resulted in increased ROS generation and led to significant suppression of cell growth in a dose-dependent manner. These cells also showed alterations in apoptosis evident in the activation of caspase-3.

SPION micelle-treated cells exhibited high levels of ROS generation concomitant with mitochondria-dependent apoptosis indicated by upregulation of caspase-3 and caspase-9, as well as high ratios of Bax/Bcl-2. The novel anticancer drug β-lapachone (β-lap) selectively suppresses the growth of cancer cells by up-regulating ROS generation. A recent study reported synergistic effects between SPION and β-lap in cancer treatment, where the authors showed that pretreatment of SPIONs prior to β-lap led to a ~10-fold increase in ROS generation relative to β-lap treatment alone, as well as increased therapeutic index of β-lap as a consequence of combination therapy. This significant synergistic effect was attributed to the Fenton reaction that enhanced the release of Fe ions by SPION micelles inside the cancer cell to interact with H2O2 produced by β-lap. This activity was attenuated upon treatment with iron chelators. In human lung cancer cells, oxidative stress mediated cell death induced by exposure to copper oxide NPs.

6. NP-Induced Modulation of ROS Generation in Stem Cell Biology

The influence of metallic NPs on mesenchymal stem cell (MSC) toxicity has been investigated. A previous report illustrated toxic behavior of ZnO NPs in bone marrow MSCs (BM-MSCs). The acidic compartment housing lysosomal enzymes led to the instability of ZnO NPs and the subsequent release of Zn+. Additionally, BM-MSCs-exposed to ZnO NPs showed dose-dependent cytotoxicity, which correlated with ROS generation. Furthermore, activation of caspase-3/7 and alterations in apoptosis were observed in ZnO NP-treated BM-MSCs.

Recently, results indicated the potential of AgNPs to promote adipogenic differentiation of human MSCs (hMSCs) in an ROS-dependent mechanism. AgNP-induced adipogenic differentiation was confirmed by the detection of lipid droplets and increases in the expression of adipogenic differentiation-related transcription factors. Moreover, the potent antibacterial activity of AgNPs enhanced hMSC adhesion. Interestingly, AgNPs did not show any negative influence on osteogenic differentiation of hMSCs. Collectively, AgNPs could be a promising nanomaterial capable of exploiting ROS-related mechanisms involved in stem cell differentiation, as well as its potential for utilization in stem cell therapy and tissue engineering.

Cerium (Ce) oxide NPs (nanoceria) are considered inorganic antioxidants capable of scavenging free radicals via similar mechanisms as those of SOD and CAT. Ce4+ and Ce3+ species located on the surface of nanoceria are implicated in modulation of redox states. The delivery of nanoceria via its encapsulation inside the biodegradable albumin NPs to finally form nanoceria encapsulated albumin nanoparticles (BCNPs) potently scavenged ROS production in hydrogen peroxide (H2O2)-exposed human lung epithelial cell line (L-132) and consequently prevented the apoptotic changes (Figure 6). Therefore, the antioxidant property of nanoceria could be exploited in the treatment and control of diseases caused by excessive ROS production.

In rat MSCs, nanoceria exposure leads to suppression of adipogenic differentiation via inhibition of ROS generation, which is essential for MSC differentiation into adipocytes. These NPs could be promising nanomaterials for obesity therapy.

A recent study reported the toxic behavior of SPIONs in neural stem cells (NSCs) attributed to their potential to disturb redox balance and increase oxidative stress. SPION-treated NSCs showed mitochondrial hyperpolarization, significant diminution in the level of intracellular GSH, cell membrane breakage, and changes in levels of GPX and SOD.

Another study investigated the effect of polysaccharide- and hydrocarbon-coated AgNPs. Both of the chemically modified AgNPs exhibited negative effects on embryonic stem cell (ESC) proliferation and self-renewal, which were induced by AgNP-induced ROS production. ESC-treated AgNPs showed cell cycle arrest at the G1/S phase; however, polysaccharide-coated AgNPs showed less ROS generation, as well as less toxic effects, as compared with those shown by hydrocarbon-coated AgNPs.

7. Conclusions

Nanotechnology offers the potential for various biomedical applications regarding cancer therapy, drug delivery, imaging, and diagnosis and therapy of Alzheimer’s and cardiovascular diseases. Current advances in NP engineering indicate that well-designed nanomaterials have the potential to improve healthcare in the future. Manufacturing of engineered nanomaterials for commercial use has also grown exponentially. As a result, the safety and toxicity of nanomaterials have become a matter of increased public attention. In this review, we described the factors involved in NP-mediated ROS generation. We also highlighted the crucial roles of NP-induced ROS modulation on cellular functions, such as toxicity, anticancer activity, and cellular differentiation via modulation of a wide range of cellular signaling pathways. Additionally, NP-induced ROS production exhibits various functions in stem cell biology. The daily exposure of the humans to nanomaterials is inevitable. Moreover, the mechanisms associated with toxicity and the hazards involved in their use resulting in NP-induced ROS remain unclear. Therefore, further studies are needed to increase the understanding of mechanisms related to ROS generation by NP. This information will be aid in the modification of the physical and chemical properties of NPs to modulate the ROS generated, enabling NPs to be exploited in various medical applications and stem cell therapeutics.

References 161

  1. 1.

    Touyz R.M. Molecular and cellular mechanisms in vascular injury in hypertension: Role of angiotensin II-editorial review. Curr. Opin. Nephrol. Hypertens. 2005;14:125-131.

    Not in our library10.1097/00041552-200503000-00007

  2. 2.

    Mueller C.F., Laude K., McNally J.S., Harrison D.G. Redox mechanisms in blood vessels. Arterioscler. Thromb. Vasc. Biol. 2005;25:274-278.

    Not in our library10.1161/01.atv.0000149143.04821.eb

  3. 3.

    Augusto O., Miyamoto S., Pantopoulos K., Schipper H. Principles of Free Radical Biomedicine. 2011.

    Not in our library

  4. 4.

    Wu H., Yin J.-J., Wamer W.G., Zeng M., Lo Y.M. Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides. J. Food Drug Anal. 2014;22:86-94.

    Not in our library10.1016/j.jfda.2014.01.007

  5. 5.

    Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006;141:312-322.

    Not in our library10.1104/pp.106.077073

  6. 6.

    Johnson F., Giulivi C. Superoxide dismutases and their impact upon human health. Mol. Asp. Med. 2005;26:340-352.

    Not in our library10.1016/j.mam.2005.07.006

  7. 7.

    Paravicini T.M., Touyz R.M. Nadph oxidases, reactive oxygen species, and hypertension clinical implications and therapeutic possibilities. Diabetes Care. 2008;31:S170-S180.

    Not in our library10.2337/dc08-s247

  8. 8.

    Brand M.D. The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 2010;45:466-472.

    Not in our library10.1016/j.exger.2010.01.003

  9. 9.

    Halliwell B., Clement M.V., Long L.H. Hydrogen peroxide in the human body. FEBS Lett. 2000;486:10-13.

    Not in our library10.1016/s0014-5793(00)02197-9

  10. 10.

    Hampton M.B., Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS Lett. 1997;414:552-556.

    Not in our library10.1016/s0014-5793(97)01068-5

  11. 11.

    Ray P.D., Huang B.-W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24:981-990.

    Not in our library10.1016/j.cellsig.2012.01.008

  12. 12.

    Guzik T.J., Harrison D.G. Vascular nadph oxidases as drug targets for novel antioxidant strategies. Drug Discov. Today. 2006;11:524-533.

    Not in our library10.1016/j.drudis.2006.04.003

  13. 13.

    Coso S., Harrison I., Harrison C.B., Vinh A., Sobey C.G., Drummond G.R., Williams E.D., Selemidis S. Nadph oxidases as regulators of tumor angiogenesis: Current and emerging concepts. Antioxid. Redox Signal. 2012;16:1229-1247.

    Not in our library10.1089/ars.2011.4489

  14. 14.

    Bedard K., Krause K.-H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 2007;87:245-313.

    Not in our library10.1152/physrev.00044.2005

  15. 15.

    Storz P. Forkhead homeobox type o transcription factors in the responses to oxidative stress. Antioxid. Redox Signal. 2011;14:593-605.

    Not in our library10.1089/ars.2010.3405

  16. 16.

    Salata O.V. Applications of nanoparticles in biology and medicine. J. Nanobiotechnol. 2004;2.

    Not in our library10.1186/1477-3155-2-3

  17. 17.

    Gonzalez L., Lison D., Kirsch-Volders M. Genotoxicity of engineered nanomaterials: A critical review. Nanotoxicology. 2008;2:252-273.

    Not in our library10.1080/17435390802464986

  18. 18.

    Brar S.K., Verma M., Tyagi R., Surampalli R. Engineered nanoparticles in wastewater and wastewater sludge-evidence and impacts. Waste Manag. 2010;30:504-520.

    Not in our library10.1016/j.wasman.2009.10.012

  19. 19.

    Chiang H.-M., Xia Q., Zou X., Wang C., Wang S., Miller B.J., Howard P.C., Yin J.J., Beland F.A., Yu H. Nanoscale zno induces cytotoxicity and DNA damage in human cell lines and rat primary neuronal cells. J. Nanosci. Nanotechnol. 2012;12:2126-2135.

    Not in our library10.1166/jnn.2012.5758

  20. 20.

    Ray P.C., Yu H., Fu P.P. Nanogold-based sensing of environmental toxins: Excitement and challenges. J. Environ. Sci. Health Part C. 2011;29:52-89.

    Not in our library10.1080/10590501.2011.551315

  21. 21.

    Poljak-Blaži M., Jaganjac M., Žarković N. Cell oxidative stress: Risk of metal nanoparticles. Handbook of Nanophysics Nanomedicine and Nanorobotic. 2010.

    Not in our library

  22. 22.

    Röcker C., Pötzl M., Zhang F., Parak W.J., Nienhaus G.U. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat. Nanotechnol. 2009;4:577-580.

    Not in our library10.1038/nnano.2009.195

  23. 23.

    Jiang X., Weise S., Hafner M., Röcker C., Zhang F., Parak W.J., Nienhaus G.U. Quantitative analysis of the protein corona on fept nanoparticles formed by transferrin binding. J. R. Soc. Interface. 2010;7:S5-S13.

    Not in our library10.1098/rsif.2009.0272.focus

  24. 24.

    Lynch I., Salvati A., Dawson K.A. Protein-nanoparticle interactions: What does the cell see? Nat. Nanotechnol. 2009;4:546-547.

    Not in our library10.1038/nnano.2009.248

  25. 25.

    Li N., Xia T., Nel A.E. The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic. Biol. Med. 2008;44:1689-1699.

    Not in our library10.1016/j.freeradbiomed.2008.01.028

  26. 26.

    Stone V., Johnston H., Clift M.J. Air pollution, ultrafine and nanoparticle toxicology: Cellular and molecular interactions. IEEE Trans. Nanobiosci. 2007;6:331-340.

    Not in our library10.1109/tnb.2007.909005

  27. 27.

    Shvedova A.A., Pietroiusti A., Fadeel B., Kagan V.E. Mechanisms of carbon nanotube-induced toxicity: Focus on oxidative stress. Toxicol. Appl. Pharmacol. 2012;261:121-133.

    Not in our library10.1016/j.taap.2012.03.023

  28. 28.

    Zhang Z., Berg A., Levanon H., Fessenden R.W., Meisel D. On the interactions of free radicals with gold nanoparticles. J. Am. Chem. Soc. 2003;125:7959-7963.

    Not in our library10.1021/ja034830z

  29. 29.

    Kennedy I.M., Wilson D., Barakat A.I. Uptake and Inflammatory Effects of Nanoparticles in a Human Vascular Endothelial Cell Line. 2009;3-32.

    Not in our library

  30. 30.

    Lee H.-M., Shin D.-M., Song H.-M., Yuk J.-M., Lee Z.-W., Lee S.-H., Hwang S.M., Kim J.-M., Lee C.-S., Jo E.-K. Nanoparticles up-regulate tumor necrosis factor-α and cxcl8 via reactive oxygen species and mitogen-activated protein kinase activation. Toxicol. Appl. Pharmacol. 2009;238:160-169.

    Not in our library10.1016/j.taap.2009.05.010

  31. 31.

    Huang Y.-W., Wu C.-H., Aronstam R.S. Toxicity of transition metal oxide nanoparticles: Recent insights from in vitro studies. Materials. 2010;3:4842-4859.

    Not in our library10.3390/ma3104842

  32. 32.

    Fubini B., Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic. Biol. Med. 2003;34:1507-1516.

    Not in our library10.1016/s0891-5849(03)00149-7

  33. 33.

    Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ros-mediated mechanisms: A radical therapeutic approach? Nat. Rev. Drug Discov. 2009;8:579-591.

    Not in our library10.1038/nrd2803

  34. 34.

    Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2000;279:L1005-L1028.

    Not in our library10.1152/ajplung.2000.279.6.l1005

  35. 35.

    Finkel T. Signal transduction by mitochondrial oxidants. J. Biol. Chem. 2012;287:4434-4440.

    Not in our library10.1074/jbc.r111.271999

  36. 36.

    Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic. Biol. Med. 2011;51:1289-1301.

    Not in our library10.1016/j.freeradbiomed.2011.06.033

  37. 37.

    Tahara E.B., Navarete F.D., Kowaltowski A.J. Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic. Biol. Med. 2009;46:1283-1297.

    Not in our library10.1016/j.freeradbiomed.2009.02.008

  38. 38.

    Okado-Matsumoto A., Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver Cu, Zn-SOD in mitochondria. J. Biol. Chem. 2001;276:38388-38393.

    Not in our library10.1074/jbc.m105395200

  39. 39.

    Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009;417:1-13.

    Not in our library10.1042/bj20081386

  40. 40.

    Finkel T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011;194:7-15.

    Not in our library10.1083/jcb.201102095

  41. 41.

    MacFie T.S., Poulsom R., Parker A., Warnes G., Boitsova T., Nijhuis A., Suraweera N., Poehlmann A., Szary J., Feakins R. DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acid. Inflamm. Bowel Dis. 2014;20:514-524.

    Not in our library10.1097/01.mib.0000442012.45038.0e

  42. 42.

    Yoshihara A., Hara T., Kawashima A., Akama T., Tanigawa K., Wu H., Sue M., Ishido Y., Hiroi N., Ishii N. Regulation of dual oxidase expression and H2O2 production by thyroglobulin. Thyroid. 2012;22:1054-1062.

    Not in our library10.1089/thy.2012.0003

  43. 43.

    Van der Vlies D., Makkinje M., Jansens A., Braakman I., Verkleij A.J., Wirtz K.W., Post J.A. Oxidation of er resident proteins upon oxidative stress: Effects of altering cellular redox/antioxidant status and implications for protein maturation. Antioxid. Redox Signal. 2003;5:381-387.

    Not in our library10.1089/152308603768295113

  44. 44.

    Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 1990;87:1620-1624.

    Not in our library10.1073/pnas.87.4.1620

  45. 45.

    Vallyathan V., Shi X. The role of oxygen free radicals in occupational and environmental lung diseases. Environ. Health Perspect. 1997;105:165-177.

    Not in our library10.1289/ehp.97105s1165

  46. 46.

    Halliwell B., Gutteridge J.M. Free Radicals in Biology and Medicine. 2015.

    Not in our library

  47. 47.

    Mignolet-Spruyt L., Xu E., Idänheimo N., Hoeberichts F.A., Mühlenbock P., Brosché M., van Breusegem F., Kangasjärvi J. Spreading the news: Subcellular and organellar reactive oxygen species production and signalling. J. Exp. Bot. 2016.

    Not in our library10.1093/jxb/erw080

  48. 48.

    Sanvicens N., Marco M.P. Multifunctional nanoparticles-properties and prospects for their use in human medicine. Trends Biotechnol. 2008;26:425-433.

    Not in our library10.1016/j.tibtech.2008.04.005

  49. 49.

    Giepmans B.N., Deerinck T.J., Smarr B.L., Jones Y.Z., Ellisman M.H. Correlated light and electron microscopic imaging of multiple endogenous proteins using quantum dots. Nat. Methods. 2005;2:743-749.

    Not in our library10.1038/nmeth791

  50. 50.

    Lindquist N.C., Nagpal P., McPeak K.M., Norris D.J., Oh S.-H. Engineering metallic nanostructures for plasmonics and nanophotonics. Rep. Prog. Phys. 2012;75:036501.

    Not in our library10.1088/0034-4885/75/3/036501

  51. 51.

    Zhang J.Z., Noguez C. Plasmonic optical properties and applications of metal nanostructures. Plasmonics. 2008;3:127-150.

    Not in our library10.1007/s11468-008-9066-y

  52. 52.

    McAteer M.A., Sibson N.R., von zur Muhlen C., Schneider J.E., Lowe A.S., Warrick N., Channon K.M., Anthony D.C., Choudhury R.P. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat. Med. 2007;13:1253-1258.

    Not in our library10.1038/nm1631

  53. 53.

    Vo-Dinh T., Cullum B. Biosensors and biochips: Advances in biological and medical diagnostics. Fresenius' Fresenius J. Anal. Chem. 2000;366:540-551.

    Not in our library10.1007/s002160051549

  54. 54.

    Li Y., Schluesener H.J., Xu S. Gold nanoparticle-based biosensors. Gold Bull. 2010;43:29-41.

    Not in our library10.1007/bf03214964

  55. 55.

    Peng H.-I., Miller B.L. Recent advancements in optical DNA biosensors: Exploiting the plasmonic effects of metal nanoparticles. Analyst. 2011;136:436-447.

    Not in our library10.1039/c0an00636j

  56. 56.

    Selid P.D., Xu H., Collins E.M., Striped Face-Collins M., Zhao J.X. Sensing mercury for biomedical and environmental monitoring. Sensors. 2009;9:5446-5459.

    Not in our library10.3390/s90705446

  57. 57.

    Koren K., Brodersen K.E., Jakobsen S.L., Kühl M. Optical sensor nanoparticles in artificial sediments—A new tool to visualize O2 dynamics around the rhizome and roots of seagrasses. Environ. Sci. Technol. 2015;49:2286-2292.

    Not in our library10.1021/es505734b

  58. 58.

    Biju V. Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem. Soc. Rev. 2014;43:744-764.

    Not in our library10.1039/c3cs60273g

  59. 59.

    Kelly K.L., Coronado E., Zhao L.L., Schatz G.C. The optical properties of metal nanoparticles: The influence of size, shape, and dielectric environment. J. Phys. Chem. B. 2003;107:668-677.

    Not in our library10.1021/jp026731y

  60. 60.

    Xu W., Xue X., Li T., Zeng H., Liu X. Ultrasensitive and selective colorimetric DNA detection by nicking endonuclease assisted nanoparticle amplification. Angew. Chem. Int. Ed. 2009;48:6849-6852.

    Not in our library10.1002/anie.200901772

  61. 61.

    Liu J., Lu Y. Colorimetric biosensors based on dnazyme-assembled gold nanoparticles. J. Fluoresc. 2004;14:343-354.

    Not in our library10.1023/b:jofl.0000031816.06134.d3

  62. 62.

    Oldenburg S.J., Genick C.C., Clark K.A., Schultz D.A. Base pair mismatch recognition using plasmon resonant particle labels. Anal. Biochem. 2002;309:109-116.

    Not in our library10.1016/s0003-2697(02)00410-4

  63. 63.

    Thanh N.T.K., Rosenzweig Z. Development of an aggregation-based immunoassay for anti-protein a using gold nanoparticles. Anal. Chem. 2002;74:1624-1628.

    Not in our library10.1021/ac011127p

  64. 64.

    Zhang C.X., Zhang Y., Wang X., Tang Z.M. Hyper-rayleigh scattering of protein-modified gold nanoparticles. Anal. Biochem. 2003;320:136-140.

    Not in our library10.1016/s0003-2697(03)00353-1

  65. 65.

    Rosarin F.S., Mirunalini S. Nobel metallic nanoparticles with novel biomedical properties. J. Bioanal. Biomed. 2011;2011.

    Not in our library10.4172/1948-593x.1000049

  66. 66.

    Agrawal A., Deo R., Wang G.D., Wang M.D., Nie S. Nanometer-scale mapping and single-molecule detection with color-coded nanoparticle probes. Proc. Natl. Acad. Sci. USA. 2008;105:3298-3303.

    Not in our library10.1073/pnas.0712351105

  67. 67.

    Willner I., Basnar B., Willner B. Nanoparticle-enzyme hybrid systems for nanobiotechnology. FEBS J. 2007;274:302-309.

    Not in our library10.1111/j.1742-4658.2006.05602.x

  68. 68.

    El-Boubbou K., Gruden C., Huang X. Magnetic glyco-nanoparticles: A unique tool for rapid pathogen detection, decontamination, and strain differentiation. J. Am. Chem. Soc. 2007;129:13392-13393.

    Not in our library10.1021/ja076086e

  69. 69.

    Georganopoulou D.G., Chang L., Nam J.-M., Thaxton C.S., Mufson E.J., Klein W.L., Mirkin C.A. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer’s disease. Proc. Natl. Acad. Sci. USA. 2005;102:2273-2276.

    Not in our library10.1073/pnas.0409336102

  70. 70.

    Cao Y.C., Jin R., Mirkin C.A. Nanoparticles with raman spectroscopic fingerprints for DNA and RNA detection. Science. 2002;297:1536-1540.

    Not in our library10.1126/science.297.5586.1536

  71. 71.

    Allen T.M., Cullis P.R. Drug delivery systems: Entering the mainstream. Science. 2004;303:1818-1822.

    Not in our library10.1126/science.1095833

  72. 72.

    Emerich D.F., Thanos C.G. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol. Eng. 2006;23:171-184.

    Not in our library10.1016/j.bioeng.2006.05.026

  73. 73.

    Wijaya A., Schaffer S.B., Pallares I.G., Hamad-Schifferli K. Selective release of multiple DNA oligonucleotides from gold nanorods. ACS Nano. 2008;3:80-86.

    Not in our library10.1021/nn800702n

  74. 74.

    Brown S.D., Nativo P., Smith J.-A., Stirling D., Edwards P.R., Venugopal B., Flint D.J., Plumb J.A., Graham D., Wheate N.J. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J. Am. Chem. Soc. 2010;132:4678-4684.

    Not in our library10.1021/ja908117a

  75. 75.

    Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine. 2007;2:681-693.

    Not in our library10.2217/17435889.2.5.681

  76. 76.

    Singh P., Kim Y.-J., Zhang D., Yang D.-C. Biological synthesis of nanoparticles from plants and microorganisms. Trends Biotechnol. 2016;34:588-599.

    Not in our library10.1016/j.tibtech.2016.02.006

  77. 77.

    Ahamed M., Alsalhi M.S., Siddiqui M. Silver nanoparticle applications and human health. Clin. Chim. Acta. 2010;411:1841-1848.

    Not in our library10.1016/j.cca.2010.08.016

  78. 78.

    Ambika S., Sundrarajan M. Green biosynthesis of ZnO nanoparticles using Vitex negundo L. Extract: Spectroscopic investigation of interaction between ZnO nanoparticles and human serum albumin. J. Photochem. Photobiol. B. 2015;149:143-148.

    Not in our library10.1016/j.jphotobiol.2015.05.004

  79. 79.

    Zahir A.A., Chauhan I.S., Bagavan A., Kamaraj C., Elango G., Shankar J., Arjaria N., Roopan S.M., Rahuman A.A., Singh N. Green synthesis of silver and titanium dioxide nanoparticles using euphorbia prostrata extract shows shift from apoptosis to G0/G1 arrest followed by necrotic cell death in leishmania donovani. Antimicrob. Agents Chemother. 2015;59:4782-4799.

    Not in our library10.1128/aac.00098-15

  80. 80.

    Risom L., Møller P., Loft S. Oxidative stress-induced DNA damage by particulate air pollution. Mutat. Res. 2005;592:119-137.

    Not in our library10.1016/j.mrfmmm.2005.06.012

  81. 81.

    Knaapen A.M., Borm P.J., Albrecht C., Schins R.P. Inhaled particles and lung cancer. Part A: Mechanisms. Int. J. Cancer. 2004;109:799-809.

    Not in our library10.1002/ijc.11708

  82. 82.

    Bonner J.C. Lung fibrotic responses to particle exposure. Toxicol. Pathol. 2007;35:148-153.

    Not in our library10.1080/01926230601060009

  83. 83.

    Ray P.C., Yu H., Fu P.P. Toxicity and environmental risks of nanomaterials: Challenges and future needs. J. Environ. Sci. Health Part C. 2009;27:1-35.

    Not in our library10.1080/10590500802708267

  84. 84.

    Nel A., Xia T., Mädler L., Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622-627.

    Not in our library10.1126/science.1114397

  85. 85.

    Xia T., Kovochich M., Liong M., Mädler L., Gilbert B., Shi H., Yeh J.I., Zink J.I., Nel A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2:2121-2134.

    Not in our library10.1021/nn800511k

  86. 86.

    Wang S., Lu W., Tovmachenko O., Rai U.S., Yu H., Ray P.C. Challenge in understanding size and shape dependent toxicity of gold nanomaterials in human skin keratinocytes. Chem. Phys. Lett. 2008;463:145-149.

    Not in our library10.1016/j.cplett.2008.08.039

  87. 87.

    Shaligram S., Campbell A. Toxicity of copper salts is dependent on solubility profile and cell type tested. Toxicol. In Vitro. 2013;27:844-851.

    Not in our library10.1016/j.tiv.2012.12.026

  88. 88.

    Lu W., Senapati D., Wang S., Tovmachenko O., Singh A.K., Yu H., Ray P.C. Effect of surface coating on the toxicity of silver nanomaterials on human skin keratinocytes. Chem. Phys. Lett. 2010;487:92-96.

    Not in our library10.1016/j.cplett.2010.01.027

  89. 89.

    Buzea C., Pacheco I.I., Robbie K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases. 2007;2:MR17-MR71.

    Not in our library10.1116/1.2815690

  90. 90.

    Wilson M.R., Lightbody J.H., Donaldson K., Sales J., Stone V. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol. Appl. Pharmacol. 2002;184:172-179.

    Not in our library10.1006/taap.2002.9501

  91. 91.
  92. 92.

    Stone V., Shaw J., Brown D., MacNee W., Faux S., Donaldson K. The role of oxidative stress in the prolonged inhibitory effect of ultrafine carbon black on epithelial cell function. Toxicol. In Vitro. 1998;12:649-659.

    Not in our library10.1016/s0887-2333(98)00050-2

  93. 93.

    Fan J., Yin J.-J., Ning B., Wu X., Hu Y., Ferrari M., Anderson G.J., Wei J., Zhao Y., Nie G. Direct evidence for catalase and peroxidase activities of ferritin-platinum nanoparticles. Biomaterials. 2011;32:1611-1618.

    Not in our library10.1016/j.biomaterials.2010.11.004

  94. 94.

    Donaldson K., Tran C.L. Inflammation caused by particles and fibers. Inhal. Toxicol. 2002;14:5-27.

    Not in our library10.1080/089583701753338613

  95. 95.
  96. 96.

    Schins R.P. Mechanisms of genotoxicity of particles and fibers. Inhal. Toxicol. 2002;14:57-78.

    Not in our library10.1080/089583701753338631

  97. 97.

    Valko M., Rhodes C., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006;160:1-40.

    Not in our library10.1016/j.cbi.2005.12.009

  98. 98.

    Aust S., Chignell C., Bray T., Kalyanaraman B., Mason R. Free radicals in toxicology. Toxicol. Appl. Pharmacol. 1993;120:168-178.

    Not in our library10.1006/taap.1993.1100

  99. 99.

    Fang G.-D., Zhou D.-M., Dionysiou D.D. Superoxide mediated production of hydroxyl radicals by magnetite nanoparticles: Demonstration in the degradation of 2-chlorobiphenyl. J. Hazard. Mater. 2013;250:68-75.

    Not in our library10.1016/j.jhazmat.2013.01.054

  100. 100.

    Roduner E. Size matters: Why nanomaterials are different. Chem. Soc. Rev. 2006;35:583-592.

    Not in our library10.1039/b502142c

  101. 101.

    Yin J.-J., Liu J., Ehrenshaft M., Roberts J.E., Fu P.P., Mason R.P., Zhao B. Phototoxicity of nano titanium dioxides in hacat keratinocytes—Generation of reactive oxygen species and cell damage. Toxicol. Appl. Pharmacol. 2012;263:81-88.

    Not in our library10.1016/j.taap.2012.06.001

  102. 102.

    Yaghini E., Pirker K., Kay C., Seifalian A., MacRobert A. Reactive oxygen species generation from photoexcited quantum dot nanoparticles: Type I versus type II photochemical mechanism. Photodiagn. Photodyn. Ther. 2011;8:151.

    Not in our library10.1016/j.pdpdt.2011.03.096

  103. 103.

    Sharma P., Jha A.B., Dubey R.S., Pessarakli M. Reactive oxygen species, oxidative damage, and antioxidative defense mechanism in plants under stressful conditions. J. Bot. 2012;2012:217037.

    Not in our library10.1155/2012/217037

  104. 104.

    Iversen T.-G., Skotland T., Sandvig K. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies. Nano Today. 2011;6:176-185.

    Not in our library10.1016/j.nantod.2011.02.003

  105. 105.

    Canton I., Battaglia G. Endocytosis at the nanoscale. Chem. Soc. Rev. 2012;41:2718-2739.

    Not in our library10.1039/c2cs15309b

  106. 106.

    Soenen S.J., Rivera-Gil P., Montenegro J.-M., Parak W.J., De Smedt S.C., Braeckmans K. Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation. Nano Today. 2011;6:446-465.

    Not in our library10.1016/j.nantod.2011.08.001

  107. 107.

    Smith K.R., Klei L.R., Barchowsky A. Arsenite stimulates plasma membrane nadph oxidase in vascular endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001;280:L442-L449.

    Not in our library10.1152/ajplung.2001.280.3.l442

  108. 108.

    Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., Sioutas C., Yeh J.I., Wiesner M.R., Nel A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6:1794-1807.

    Not in our library10.1021/nl061025k

  109. 109.

    AshaRani P., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2008;3:279-290.

    Not in our library10.1021/nn800596w

  110. 110.

    Holt K.B., Bard A.J. Interaction of Silver (I) ions with the respiratory chain of escherichia coli: An electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+. Biochemistry. 2005;44:13214-13223.

    Not in our library10.1021/bi0508542

  111. 111.

    Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin. Interv. Aging. 2007;2:219.

    Not in our library

  112. 112.

    Fenoglio I., Corazzari I., Francia C., Bodoardo S., Fubini B. The oxidation of glutathione by cobalt/tungsten carbide contributes to hard metal-induced oxidative stress. Free Radic. Res. 2008;42:437-745.

    Not in our library10.1080/10715760802350904

  113. 113.

    Zhang H., Ji Z., Xia T., Meng H., Low-Kam C., Liu R., Pokhrel S., Lin S., Wang X., Liao Y.-P. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano. 2012;6:4349-4368.

    Not in our library10.1021/nn3010087

  114. 114.

    Xu Q., He C., Xiao C., Chen X. Reactive oxygen species (ROS) responsive polymers for biomedical applications. Macromol. Biosci. 2016.

    Not in our library10.1002/mabi.201500440

  115. 115.

    Tapeinos C., Pandit A. Physical, chemical, and biological structures based on ros-sensitive moieties that are able to respond to oxidative microenvironments. Adv. Mater. 2016;28.

    Not in our library10.1002/adma.201505376

  116. 116.

    Zhu X., Hondroulis E., Liu W., Li C.Z. Biosensing approaches for rapid genotoxicity and cytotoxicity assays upon nanomaterial exposure. Small. 2013;9:1821-1830.

    Not in our library10.1002/smll.201201593

  117. 117.

    Xie H., Mason M.M., Wise J.P. Genotoxicity of metal nanoparticles. Rev. Environ. Health. 2011;26:251-268.

    Not in our library10.1515/reveh.2011.033

  118. 118.

    Valavanidis A., Vlachogianni T., Fiotakis C. 8-hydroxy-2’-deoxyguanosine (8-OHDG): A critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health Part C. 2009;27:120-139.

    Not in our library10.1080/10590500902885684

  119. 119.

    Inoue K.-I., Takano H., Yanagisawa R., Hirano S., Sakurai M., Shimada A., Yoshikawa T. Effects of airway exposure to nanoparticles on lung inflammation induced by bacterial endotoxin in mice. Environ. Health Perspect. 2006;1325-1330.

    Not in our library10.1289/ehp.8903

  120. 120.

    Eblin K., Bowen M., Cromey D., Bredfeldt T., Mash E.A., Lau S., Gandolfi A.J. Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell culture. Toxicol. Appl. Pharmacol. 2006;217:7-14.

    Not in our library10.1016/j.taap.2006.07.004

  121. 121.

    Song M.-F., Li Y.-S., Kasai H., Kawai K. Metal nanoparticle-induced micronuclei and oxidative DNA damage in mice. J. Clin. Biochem. Nutr. 2012;50:211-216.

    Not in our library10.3164/jcbn.11-70

  122. 122.

    Howden P.J., Faux S.P. Fibre-induced lipid peroxidation leads to DNA adduct formation in salmonella typhimurium ta104 and rat lung fibroblasts. Carcinogenesis. 1996;17:413-419.

    Not in our library10.1093/carcin/17.3.413

  123. 123.

    Shukla R.K., Sharma V., Pandey A.K., Singh S., Sultana S., Dhawan A. Ros-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells. Toxicol. In Vitro. 2011;25:231-241.

    Not in our library10.1016/j.tiv.2010.11.008

  124. 124.

    Turski M.L., Thiele D.J. New roles for copper metabolism in cell proliferation, signaling, and disease. J. Biol. Chem. 2009;284:717-721.

    Not in our library10.1074/jbc.r800055200

  125. 125.

    Li Y., Yu S., Wu Q., Tang M., Pu Y., Wang D. Chronic Al2O3-nanoparticle exposure causes neurotoxic effects on locomotion behaviors by inducing severe ROS production and disruption of ROS defense mechanisms in nematode caenorhabditis elegans. J. Hazard. Mater. 2012;219:221-230.

    Not in our library10.1016/j.jhazmat.2012.03.083

  126. 126.

    Park E.-J., Yoon J., Choi K., Yi J., Park K. Induction of chronic inflammation in mice treated with titanium dioxide nanoparticles by intratracheal instillation. Toxicology. 2009;260:37-46.

    Not in our library10.1016/j.tox.2009.03.005

  127. 127.

    Maurer-Jones M.A., Lin Y.-S., Haynes C.L. Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano. 2010;4:3363-3373.

    Not in our library10.1021/nn9018834

  128. 128.

    Li J.J., Hartono D., Ong C.-N., Bay B.-H., Yung L.-Y.L. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials. 2010;31:5996-6003.

    Not in our library10.1016/j.biomaterials.2010.04.014

  129. 129.

    Fan Z., Lu J.G. Zinc oxide nanostructures: Synthesis and properties. J. Nanosci. Nanotechnol. 2005;5:1561-1573.

    Not in our library10.1166/jnn.2005.182

  130. 130.

    Girgis E., Khalil W., Emam A., Mohamed M., Rao K.V. Nanotoxicity of gold and gold-cobalt nanoalloy. Chem. Res. Toxicol. 2012;25:1086-1098.

    Not in our library10.1021/tx300053h

  131. 131.

    Shvedova A., Castranova V., Kisin E., Schwegler-Berry D., Murray A., Gandelsman V., Maynard A., Baron P. Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Environ. Health Part A. 2003;66:1909-1926.

    Not in our library10.1080/713853956

  132. 132.

    Hsin Y.-H., Chen C.-F., Huang S., Shih T.-S., Lai P.-S., Chueh P.J. The apoptotic effect of nanosilver is mediated by a ROS-and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol. Lett. 2008;179:130-139.

    Not in our library10.1016/j.toxlet.2008.04.015

  133. 133.

    Mei N., Zhang Y., Chen Y., Guo X., Ding W., Ali S.F., Biris A.S., Rice P., Moore M.M., Chen T. Silver nanoparticle-induced mutations and oxidative stress in mouse lymphoma cells. Environ. Mol. Mutagen. 2012;53:409-419.

    Not in our library10.1002/em.21698

  134. 134.

    Lee Y.-H., Cheng F.-Y., Chiu H.-W., Tsai J.-C., Fang C.-Y., Chen C.-W., Wang Y.-J. Cytotoxicity, oxidative stress, apoptosis and the autophagic effects of silver nanoparticles in mouse embryonic fibroblasts. Biomaterials. 2014;35:4706-4715.

    Not in our library10.1016/j.biomaterials.2014.02.021

  135. 135.

    Quinteros M., Aristizábal V.C., Dalmasso P., Paraje M., Páez P. Oxidative stress generation of silver nanoparticles in three bacterial genera and its relationship with the antimicrobial activity. Toxicol. In Vitro. 2016;36:216-223.

    Not in our library10.1016/j.tiv.2016.08.007

  136. 136.

    Sawai J., Shoji S., Igarashi H., Hashimoto A., Kokugan T., Shimizu M., Kojima H. Hydrogen peroxide as an antibacterial factor in zinc oxide powder slurry. J. Ferment. Bioeng. 1998;86:521-522.

    Not in our library10.1016/s0922-338x(98)80165-7

  137. 137.
  138. 138.

    Lipovsky A., Nitzan Y., Gedanken A., Lubart R. Antifungal activity of zno nanoparticles—The role of ros mediated cell injury. Nanotechnology. 2011;22:105101.

    Not in our library10.1088/0957-4484/22/10/105101

  139. 139.
  140. 140.

    Dayem A.A., Kim B., Gurunathan S., Choi H.Y., Yang G., Saha S.K., Han D., Han J., Kim K., Kim J.H. Biologically synthesized silver nanoparticles induce neuronal differentiation of SH-SY5Y cells via modulation of reactive oxygen species, phosphatases, and kinase signaling pathways. Biotechnol. J. 2014;9:934-943.

    Not in our library10.1002/biot.201400555

  141. 141.

    Moosavi M.A., Sharifi M., Ghafary S.M., Mohammadalipour Z., Khataee A., Rahmati M., Hajjaran S., Łos M.J., Klonisch T., Ghavami S. Photodynamic N-TiO2 nanoparticle treatment induces controlled Ros-mediated autophagy and terminal differentiation of leukemia cells. Sci. Rep. 2016;6.

    Not in our library10.1038/srep34413

  142. 142.

    Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer. 2011;11:85-95.

    Not in our library10.1038/nrc2981

  143. 143.

    Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995;358:1-3.

    Not in our library10.1016/0014-5793(94)01368-b

  144. 144.

    Pelicano H., Carney D., Huang P. Ros stress in cancer cells and therapeutic implications. Drug Resist. Updat. 2004;7:97-110.

    Not in our library10.1016/j.drup.2004.01.004

  145. 145.

    Ahamed M., Khan M.M., Akhtar M.J., Alhadlaq H.A., Alshamsan A. Role of Zn doping in oxidative stress mediated cytotoxicity of TiO2 nanoparticles in human breast cancer MCF-7 cells. Sci. Rep. 2016;6.

    Not in our library10.1038/srep30196

  146. 146.

    Setyawati M.I., Tay C.Y., Leong D.T. Effect of zinc oxide nanomaterials-induced oxidative stress on the p53 pathway. Biomaterials. 2013;34:10133-10142.

    Not in our library10.1016/j.biomaterials.2013.09.024

  147. 147.
  148. 148.

    Liu Y., Li X., Bao S., Lu Z., Li Q., Li C.M. Plastic protein microarray to investigate the molecular pathways of magnetic nanoparticle-induced nanotoxicity. Nanotechnology. 2013;24:175501.

    Not in our library10.1088/0957-4484/24/17/175501

  149. 149.

    Huang G., Chen H., Dong Y., Luo X., Yu H., Moore Z., Bey E.A., Boothman D.A., Gao J. Superparamagnetic iron oxide nanoparticles: Amplifying ROS stress to improve anticancer drug efficacy. Theranostics. 2013;3:116-126.

    Not in our library10.7150/thno.5411

  150. 150.

    Ahamed M., Siddiqui M.A., Akhtar M.J., Ahmad I., Pant A.B., Alhadlaq H.A. Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells. Biochem. Biophys. Res. Commun. 2010;396:578-583.

    Not in our library10.1016/j.bbrc.2010.04.156

  151. 151.

    Akhtar M.J., Kumar S., Alhadlaq H.A., Alrokayan S.A., Abu-Salah K.M., Ahamed M. Dose-dependent genotoxicity of copper oxide nanoparticles stimulated by reactive oxygen species in human lung epithelial cells. Toxicol. Ind. Health. 2016;32:809-821.

    Not in our library10.1177/0748233713511512

  152. 152.

    Syama S., Sreekanth P., Varma H., Mohanan P. Zinc oxide nanoparticles induced oxidative stress in mouse bone marrow mesenchymal stem cells. Toxicol. Mech. Methods. 2014;24:644-653.

    Not in our library10.3109/15376516.2014.956914

  153. 153.

    He W., Elkhooly T.A., Liu X., Cavallaro A., Taheri S., Vasilev K., Feng Q. Silver nanoparticle based coatings enhance adipogenesis compared to osteogenesis in human mesenchymal stem cells through oxidative stress. J. Mater. Chem. B. 2016;4:1466-1479.

    Not in our library10.1039/c5tb02482j

  154. 154.

    Celardo I., de Nicola M., Mandoli C., Pedersen J.Z., Traversa E., Ghibelli L. Ce3+ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles. ACS Nano. 2011;5:4537-4549.

    Not in our library10.1021/nn200126a

  155. 155.

    Heckert E.G., Karakoti A.S., Seal S., Self W.T. The role of cerium redox state in the sod mimetic activity of nanoceria. Biomaterials. 2008;29:2705-2709.

    Not in our library10.1016/j.biomaterials.2008.03.014

  156. 156.

    Celardo I., Traversa E., Ghibelli L. Cerium oxide nanoparticles: A promise for applications in therapy. J. Exp. Ther. Oncol. 2011;9:47-51.

    Not in our library

  157. 157.

    Karakoti A.S., Munusamy P., Hostetler K., Kodali V., Kuchibhatla S., Orr G., Pounds J.G., Teeguarden J.G., Thrall B.D., Baer D.R. Preparation and characterization challenges to understanding environmental and biological impacts of ceria nanoparticles. Surf. Interface Anal. 2012;44:882-889.

    Not in our library10.1002/sia.5006

  158. 158.

    Bhushan B., Gopinath P. Antioxidant nanozyme: A facile synthesis and evaluation of the reactive oxygen species scavenging potential of nanoceria encapsulated albumin nanoparticles. J. Mater. Chem. B. 2015;3:4843-4852.

    Not in our library10.1039/c5tb00572h

  159. 159.

    Rocca A., Mattoli V., Mazzolai B., Ciofani G. Cerium oxide nanoparticles inhibit adipogenesis in rat mesenchymal stem cells: Potential therapeutic implications. Pharm. Res. 2014;31:2952-2962.

    Not in our library10.1007/s11095-014-1390-7

  160. 160.

    Pongrac I.M., Pavičić I., Milić M., Ahmed L.B., Babič M., Horák D., Vrček I.V., Gajović S. Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles. Int. J. Nanomed. 2016;11:1701-1715.

    Not in our library10.2147/ijn.s102730

  161. 161.

    Rajanahalli P., Stucke C.J., Hong Y. The effects of silver nanoparticles on mouse embryonic stem cell self-renewal and proliferation. Toxicol. Rep. 2015;2:758-764.

    Not in our library10.1016/j.toxrep.2015.05.005

Cited by papers we hold 14

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.